J&J Procrit Promotional Claims Encourage Excess Dosing, FDA Says
Executive Summary
Johnson & Johnson's promotional materials for Procrit encourage inappropriate dosing of the anemia drug, CBER's Advertising & Promotional Labeling Branch says in a June 20 letter